Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.293
-0.010 (-3.40%)
At close: Jul 19, 2024, 4:00 PM
0.300
+0.007 (2.49%)
Pre-market: Jul 22, 2024, 7:16 AM EDT
Renalytix Market Cap
Renalytix has a market cap or net worth of $26.57 million as of July 22, 2024. Its market cap has decreased by -75.23% in one year.
Market Cap
26.57M
Enterprise Value
31.29M
1-Year Change
-75.23%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since July 17, 2020, Renalytix's market cap has decreased from $475.30M to $26.57M, a decrease of -94.41%. That is a compound annual growth rate of -51.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 22.60M | 18.95% |
| Dec 29, 2023 | 19.00M | -72.86% |
| Dec 30, 2022 | 70.00M | -87.81% |
| Dec 31, 2021 | 574.30M | -0.33% |
| Dec 31, 2020 | 576.20M | 21.23% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 27.92M |
| Bolt Biotherapeutics | 27.87M |
| RenovoRx | 27.78M |
| Brainstorm Cell Therapeutics | 27.56M |
| Acasti Pharma | 26.69M |
| Autonomix Medical | 26.50M |
| SAB Biotherapeutics | 26.21M |
| Beyond Air | 26.06M |